224 related articles for article (PubMed ID: 24402235)
1. The E. coli CNF1 as a pioneering therapy for the central nervous system diseases.
Travaglione S; Loizzo S; Ballan G; Fiorentini C; Fabbri A
Toxins (Basel); 2014 Jan; 6(1):270-82. PubMed ID: 24402235
[TBL] [Abstract][Full Text] [Related]
2. Effects of the
Carlini F; Maroccia Z; Fiorentini C; Travaglione S; Fabbri A
Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830494
[TBL] [Abstract][Full Text] [Related]
3. CNF1 improves astrocytic ability to support neuronal growth and differentiation in vitro.
Malchiodi-Albedi F; Paradisi S; Di Nottia M; Simone D; Travaglione S; Falzano L; Guidotti M; Frank C; Cutarelli A; Fabbri A; Fiorentini C
PLoS One; 2012; 7(4):e34115. PubMed ID: 22523545
[TBL] [Abstract][Full Text] [Related]
4. The Bacterial Toxin CNF1 Induces Activation and Maturation of Human Monocyte-Derived Dendritic Cells.
Gall-Mas L; Fabbri A; Namini MRJ; Givskov M; Fiorentini C; Krejsgaard T
Int J Mol Sci; 2018 May; 19(5):. PubMed ID: 29738516
[TBL] [Abstract][Full Text] [Related]
5. Activation of Rho GTPases triggers structural remodeling and functional plasticity in the adult rat visual cortex.
Cerri C; Fabbri A; Vannini E; Spolidoro M; Costa M; Maffei L; Fiorentini C; Caleo M
J Neurosci; 2011 Oct; 31(42):15163-72. PubMed ID: 22016550
[TBL] [Abstract][Full Text] [Related]
6. The Rac GTPase-activating bacterial protein toxin CNF1 induces analgesia up-regulating mu-opioid receptors.
Pavone F; Luvisetto S; Marinelli S; Straface E; Fabbri A; Falzano L; Fiorentini C; Malorni W
Pain; 2009 Sep; 145(1-2):219-29. PubMed ID: 19608345
[TBL] [Abstract][Full Text] [Related]
7. The Rho GTPase activators CNF1 and DNT bacterial toxins have mucosal adjuvant properties.
Munro P; Flatau G; Anjuère F; Hofman V; Czerkinsky C; Lemichez E
Vaccine; 2005 Apr; 23(20):2551-6. PubMed ID: 15780436
[TBL] [Abstract][Full Text] [Related]
8. Cytotoxic necrotizing factor-2 of Escherichia coli alters the morphology of cultured hippocampal neurons.
Boutillier S; Rapp J; Staeb T; Olenik C; Schmidt G; Meyer DK; Leemhuis J
Naunyn Schmiedebergs Arch Pharmacol; 2003 Dec; 368(6):513-9. PubMed ID: 14605794
[TBL] [Abstract][Full Text] [Related]
9. Activation and proteasomal degradation of rho GTPases by cytotoxic necrotizing factor-1 elicit a controlled inflammatory response.
Munro P; Flatau G; Doye A; Boyer L; Oregioni O; Mege JL; Landraud L; Lemichez E
J Biol Chem; 2004 Aug; 279(34):35849-57. PubMed ID: 15152002
[TBL] [Abstract][Full Text] [Related]
10. Long-lasting efficacy of the cognitive enhancer cytotoxic necrotizing factor 1.
Borrelli S; Musilli M; Martino A; Diana G
Neuropharmacology; 2013 Jan; 64():74-80. PubMed ID: 22659407
[TBL] [Abstract][Full Text] [Related]
11. Expression and cytoprotective activity of the small GTPase RhoB induced by the Escherichia coli cytotoxic necrotizing factor 1.
Huelsenbeck SC; Roggenkamp D; May M; Huelsenbeck J; Brakebusch C; Rottner K; Ladwein M; Just I; Fritz G; Schmidt G; Genth H
Int J Biochem Cell Biol; 2013 Aug; 45(8):1767-75. PubMed ID: 23732113
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic effects of the Rho GTPase modulator CNF1 in a model of Parkinson's disease.
Musilli M; Ciotti MT; Pieri M; Martino A; Borrelli S; Dinallo V; Diana G
Neuropharmacology; 2016 Oct; 109():357-365. PubMed ID: 27350290
[TBL] [Abstract][Full Text] [Related]
13. Bacterial Toxins and Targeted Brain Therapy: New Insights from Cytotoxic Necrotizing Factor 1 (CNF1).
Tantillo E; Colistra A; Vannini E; Cerri C; Pancrazi L; Baroncelli L; Costa M; Caleo M
Int J Mol Sci; 2018 May; 19(6):. PubMed ID: 29857515
[TBL] [Abstract][Full Text] [Related]
14. The cytotoxic necrotizing factor 1 (CNF1) from Escherichia coli.
Boquet P
Toxicon; 2001 Nov; 39(11):1673-80. PubMed ID: 11595630
[TBL] [Abstract][Full Text] [Related]
15. The bacterial protein toxin, cytotoxic necrotizing factor 1 (CNF1) provides long-term survival in a murine glioma model.
Vannini E; Panighini A; Cerri C; Fabbri A; Lisi S; Pracucci E; Benedetto N; Vannozzi R; Fiorentini C; Caleo M; Costa M
BMC Cancer; 2014 Jun; 14():449. PubMed ID: 24939046
[TBL] [Abstract][Full Text] [Related]
16. Escherichia coli cytotoxic necrotizing factor 1 (CNF1), a toxin that activates the Rho GTPase.
Fiorentini C; Fabbri A; Flatau G; Donelli G; Matarrese P; Lemichez E; Falzano L; Boquet P
J Biol Chem; 1997 Aug; 272(31):19532-7. PubMed ID: 9235957
[TBL] [Abstract][Full Text] [Related]
17. Inactivation of small Rho GTPases by the multifunctional RTX toxin from Vibrio cholerae.
Sheahan KL; Satchell KJ
Cell Microbiol; 2007 May; 9(5):1324-35. PubMed ID: 17474905
[TBL] [Abstract][Full Text] [Related]
18. Rho-activating Escherichia coli cytotoxic necrotizing factor 1: macropinocytosis of apoptotic bodies in human epithelial cells.
Fabbri A; Falzano L; Travaglione S; Stringaro A; Malorni W; Fais S; Fiorentini C
Int J Med Microbiol; 2002 Feb; 291(6-7):551-4. PubMed ID: 11890557
[TBL] [Abstract][Full Text] [Related]
19. Cytotoxic necrotizing factor 1 from Escherichia coli: a toxin with a new intracellular activity for eukaryotic cells.
Boquet P
Folia Microbiol (Praha); 1998; 43(3):285-9. PubMed ID: 9717256
[TBL] [Abstract][Full Text] [Related]
20. Cytotoxic necrotizing factor 1 prevents apoptosis via the Akt/IkappaB kinase pathway: role of nuclear factor-kappaB and Bcl-2.
Miraglia AG; Travaglione S; Meschini S; Falzano L; Matarrese P; Quaranta MG; Viora M; Fiorentini C; Fabbri A
Mol Biol Cell; 2007 Jul; 18(7):2735-44. PubMed ID: 17507655
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
